Glucagon-like peptide-1 agonism - GLP-1, common in obesity medicines - is not essential to weight management, according to preclinical research led by Richard DiMarchi and Matthias Tschöp, with funding from their startup company Bluewater Biosciences.
I mean to be fair there’s also other reasons to forget to eat (AuDHD gang here, haha)
(we DO get hungry though, and then just… still don’t eat. executive dysfunction is a fuck)
– Frost